Figure 4.
MAP at study entry and day 28 post-HCT. (A) Median MAP at study entry (day 7 or 14 post-HCT) in AAT-treated patients (0.22, n = 30) and controls (0.23, n = 90). (B) Median MAP at day 28 post-HCT in AAT-treated patients (0.10, n = 30) and controls (0.14, n = 82). Box and whisker plots show median MAP with whiskers extending from the 10th to the 90th percentile. Values outside this range are drawn as individual points.